Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction

Current Hypertension Reviews

Volumn 4, Issue 4, 2008, Pages 245-255

  Chen, Xiuping ^a,b   Andresen, Bradley T ^a,c   Hill, Michael ^b   Zhang, Jing ^a,b   Booth, Frank ^b,d   Zhang, Cuihua ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cardiovascular disease; Endothelial cell; Inflammation; Mitochondria; NAD(P)H oxidase; Nitric oxide

Indexed keywords

CERAMIDE; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

EID: 70350022769     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340208786241336     Document Type: Review

References (133)

1. Mantovani A, Sozzani S, Introna M. Endothelial activation by cytokines. Ann NY Acad Sci 1997; 832: 93-116.
2. Stenvinkel P. Endothelial dysfunction and inflammation-is there a link? Nephrol Dial Transplant 2001; 16: 1968-71.
3. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: H985-1002.
4. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552: 335-44.
5. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1005-28.
6. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001; 31: 1287-312.
7. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 2000; 88: 1880-9.
8. Droge W. Oxidative stress and aging. Adv Exp Med Biol 2003; 543: 191-200.
9. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
10. Kowaltowski AJ, Vercesi AE. Reactive oxygen generation by mitochondria. Mitochondria in Pathogenesis 2002; 281-300.
11. Shah AM, Channon KM. Free radicals and redox signalling in cardiovascular disease. Heart 2004; 90: 486-7.
12. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001; 89: 224-36.
13. Azevedo LC, Janiszewski M, Soriano FG, et al. Redox mechanisms of vascular cell dysfunction in sepsis. Endocr Metab Immune Disord Drug Targets 2006; 6: 159-64.
14. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122: 339-52.
15. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-70.
16. Pober JS, Min W. Endothelial cell dysfunction, injury and death. Handb Exp Pharmacol 2006; 135-56.
17. Luster MI, Simeonova PP, Gallucci R, et al. Tumor necrosis factor alpha and toxicology. Crit Rev Toxicol 1999; 29: 491-511.
18. Beyaert R, Fiers W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett 1994; 340: 9-16.
19. Shen HM, Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 2006; 20: 1589-98.
20. Pober JS. Endothelial activation: intracellular signaling pathways. Arthritis Res 2002; 4 Suppl 3: S109-16.
21. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
22. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994; 9: 10771-8.
23. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 1984; 105: 429-35.
24. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992; 267: 5317-23.
25. Schulze-Osthoff K, Beyaert R, Vandevoorde V, et al. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993; 12: 3095-104.
26. Goossens V, Grooten J, De Vos K, et al. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 1995; 92: 8115-9.
27. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, et al. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 1997; 273: G7-17.
28. Chen KH, Reece LM, Leary JF. Mitochondrial glutathione modulates TNF-alpha-induced endothelial cell dysfunction. Free Radic Biol Med 1999; 27: 100-9.
29. Marchesini N, Hannun YA. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 2004; 82: 27-44.
30. Chatterjee S. Neutral sphingomyelinase: past, present and future. Chem Phys Lipids 1999; 102: 79-96.
31. Goni FM, Alonso A. Sphingomyelinases: enzymology and membrane activity. FEBS Lett 2002; 531: 38-46.
32. Corda S, Laplace C, Vicaut E, et al. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 2001; 24: 762-8.
33. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-4.
34. Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005; 109: 217-26.
35. Ago T, Nunoi H, Ito T, et al. Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem 1999; 274: 33644-53.
36. Finan P, Shimizu Y, Gout I, et al. An SH3 domain and proline-rich sequencez mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem 1994; 269: 13752-5.
37. Leto TL, Adams AG, de Mendez I. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc Natl Acad Sci USA 1994; 91: 10650-4.
38. Sumimoto H, Kage Y, Nunoi H, et al. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA 1994; 91: 5345-9.
39. Ito T, Matsui Y, Ago T, et al. Novel modular domain PB1 recognizes PC motif to mediate functional protein-protein interactions. EMBO J 2001; 20: 3938-46.
40. Tsunawaki S, Mizunari H, Nagata M, et al. A novel cytosolic component, p40phox, of respiratory burst oxidase associates with p67phox and is absent in patients with chronic granulomatous disease who lack p67phox. Biochem Biophys Res Commun 1994; 199: 1378-87.
41. Leusen JH, Bolscher BG, Hilarius PM, et al. 156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med 1994; 180: 2329-34.
42. Dang PM, Cross AR, Babior BM. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558. Proc Natl Acad Sci USA 2001; 98: 3001-5.
43. Dang PM, Cross AR, Quinn MT, et al. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci USA 2002; 99: 4262-5.
44. Han CH, Freeman JL, Lee T, et al. Regulation of the neutrophil respiratory burst oxidase. Identification of an activation domain in p67(phox). J Biol Chem 1998; 273: 16663-8.
45. Nisimoto Y, Motalebi S, Han CH, et al. The p67(phox) activation domain regulates electron flow from NADPH to flavin in flavocy-tochrome b(558). J Biol Chem 1999; 274: 22999-3005.
46. Diebold BA, Bokoch GM. Molecular basis for Rac2 regulation of phagocyte NADPH oxidase. Nat Immunol 2001; 2: 211-5.
47. Koga H, Terasawa H, Nunoi H, et al. Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 1999; 274: 25051-60.
48. Takeya R, Sumimoto H. Molecular mechanism for activation of superoxide-producing NADPH oxidases. Mol Cells 2003; 16: 271-7.
49. Rotrosen D, Yeung CL, Leto TL, et al. Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. Science 1992; 256: 1459-62.
50. Ago T, Kitazono T, Kuroda J, et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 2005; 36: 1040-6.
51. Ago T, Kitazono T, Ooboshi H, et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004; 109: 227-33.
52. BelAiba RS, Djordjevic T, Petry A, et al. NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 2007; 42: 446-59.
53. Petry A, Djordjevic T, Weitnauer M, et al. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 2006; 8: 1473-84.
54. Van Buul JD, Fernandez-Borja M, Anthony EC, et al. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 2005; 7: 308-17.
55. Datla SR, Peshavariya H, Dusting GJ, et al. Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vasc Biol 2007; 27: 2319-24.
56. Li JM, Fan LM, George VT, et al. Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. Free Radic Biol Med 2007; 43: 976-86.
57. De Keulenaer GW, Alexander RW, Ushio-Fukai M, et al. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998; 329 (Pt 3): 653-7.
58. Muzaffar S, Shukla N, Angelini GD, et al. Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost. Eur J Pharmacol 2006; 538: 108-14.
59. Muzaffar S, Shukla N, Angelini G, et al. Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation 2004; 110: 1140-7.
60. Li JM, Mullen AM, Yun S, et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 2002; 90: 143-50.
61. Park L, Anrather J, Zhou P, et al. Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and - independent mechanisms. Arterioscler Thromb Vasc Biol 2004; 24: 1860-5.
62. Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev 1998; 12: 2821-30.
63. Xu YC, Wu RF, Gu Y, et al. Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. J Biol Chem 2002; 277: 28051-7.
64. Li JM, Fan LM, Christie MR, et al. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005; 25: 2320-30.
65. Bereta J, Bereta M, Allison AC, et al. Inhibitory effect of dicatechol rooperol on VCAM-1 and iNOS expression in cytokine-stimulated endothelium. Life Sci 1997; 60: 325-34.
66. Deshpande SS, Angkeow P, Huang J, et al. Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J 2000; 14: 1705-14.
67. Mukherjee TK, Mukhopadhyay S, Hoidal JR. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 2005; 1744: 213-23.
68. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
69. MacNaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993; 196: 1330-4.
70. Xia Z, Liu M, Wu Y, et al. N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. Eur J Pharmacol 2006; 550: 134-42.
71. Zhang J, Patel JM, Li YD, et al. Proinflammatory cytokines down-regulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Res Commun Mol Pathol Pharmacol 1997; 96: 71-87.
72. Seidel M, Billert H, Kurpisz M. Regulation of eNOS expression in HCAEC cell line treated with opioids and proinflammatory cytokines. Kardiol Pol 2006; 64: 153-8; discussion 9-60.
73. Goodwin BL, Pendleton LC, Levy MM, et al. Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. Am J Physiol Heart Circ Physiol 2007; 293: H1115-21.
74. De Palma C, Meacci E, Perrotta C, et al. Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler Thromb Vasc Biol 2006; 26: 99-105.
75. Zhang C, Hein TW, Wang W, et al. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol 2006; 40: 247-57.
76. Jantzen F, Konemann S, Wolff B, et al. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. J Physiol Pharmacol 2007; 58: 503-14.
77. Murata J, Corradin SB, Janzer RC, et al. Tumor cells suppress cytokine-induced nitric-oxide (NO) production in cerebral endothelial cells. Int J Cancer 1994; 59: 699-705.
78. Scalera F. Intracellular glutathione and lipid peroxide availability and the secretion of vasoactive substances by human umbilical vein endothelial cells after incubation with TNF-alpha. Eur J Clin Invest 2003; 33: 176-82.
79. Ma ZC, Gao Y, Wang J, et al. Proteomic analysis effects of ginsenoside Rg1 on human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha. Life Sci 2006; 79: 175-81.
80. Zhou Z, Wang SQ, Liu Y, et al. Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells. Biochim Biophys Acta 2006; 1760: 1-9.
81. Yang B, Rizzo V. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 2007; 292: H954-62.
82. Morikawa A, Koide N, Kato Y, et al. Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 2000; 68: 6209-14.
83. Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solutions. Inorg Chem 1985; 24: 3504-5.
84. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
85. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-6.
86. Gorren AC, de Boer E, Wever R. The reaction of nitric oxide with copper proteins and the photodissociation of copper-NO complexes. Biochim Biophys Acta 1987; 916: 38-47.
87. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
88. Phelps DT, Ferro TJ, Higgins PJ, et al. TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995; 269: L551-9.
89. Neumann P, Gertzberg N, Vaughan E, et al. Peroxynitrite mediates TNF-alpha-induced endothelial barrier dysfunction and nitration of actin. Am J Physiol Lung Cell Mol Physiol 2006; 290: L674-L84.
90. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006; 58: 87-114.
91. Friedl HP, Till GO, Ryan US, et al. Mediator-induced activation of xanthine oxidase in endothelial cells. Faseb J 1989; 3: 2512-8.
92. Eligini S, Barbieri SS, Cavalca V, et al. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. Cardiovasc Res 2005; 65: 683-93.
93. Schmeck B, Brunsch M, Seybold J, et al. Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells. Inflammation 2003; 27: 89-95.
94. Sasaki M, Ostanin D, Elrod JW, et al. TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent. Am J Physiol Cell Physiol 2003; 284: C422-8.
95. Monshouwer M, Witkamp RF, Nujmeijer SM, et al. Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol 1996; 137: 237-44.
96. Arai T, Kelly SA, Brengman ML, Takano M, Smith EH, et al. Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor alpha in endothelium. Biochem J 1998; 331 (Pt 3): 853-61.
97. Marzinzig M, Nussler AK, Stadler J, et al. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1997; 1: 177-89.
98. Chen XP, Du GH. Dichlorodihydrofluorescin diacetate, forty years' application and controversy. Herald Med 2007; 26: 343-9.
99. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care 2003; 7: 130-8.
100. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-92.
101. Shakibaei M, Schulze-Tanzil G, Takada Y, et al. Redox regulation of apoptosis by members of the TNF superfamily. Antioxid Redox Signal 2005; 7: 482-96.
102. Karihtala P, Soini Y, Auvinen P, et al. Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation. J Histochem Cytochem 2007; 55: 1191-8.
103. Suematsu N, Tsutsui H, Wen J, et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003; 107: 1418-23.
104. Wheelhouse NM, Chan YS, Gillies SE, et al. TNF-alpha induced DNA damage in primary murine hepatocytes. Int J Mol Med 2003; 12: 889-94.
105. Park YM, Han MY, Blackburn RV, et al. Overexpression of HSP25 reduces the level of TNF alpha-induced oxidative DNA damage biomarker, 8-hydroxy-2′-deoxyguanosine, in L929 cells. J Cell Physiol 1998; 174: 27-34.
106. Reese BE, Davidson C, Billingsley ML, et al. Protein kinase C epsilon regulates tumor necrosis factor-alpha-induced stannin gene expression. J Pharmacol Exp Ther 2005; 314: 61-9.
107. Rogers RJ, Monnier JM, Nick HS. Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. J Biol Chem 2001; 276: 20419-27.
108. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 1992; 262: C854-61.
109. Corder R, Carrier M, Khan N, et al. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J Cardiovasc Pharmacol 1995; 26 Suppl 3: S56-8.
110. Tang C, Wu AH, Xue HL, et al. Tanshinone IIA inhibits endothelin-1 production in TNF-alpha-induced brain microvascular endothelial cells through suppression of endothelin-converting enzyme-1 synthesis. Acta Pharmacol Sin 2007; 28: 1116-22.
111. Zhao RZ, Chen X, Yao Q, et al. TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways. Biochem Biophys Res Commun 2005; 327: 985-92.
112. Tanaka N, Yonekura H, Yamagishi S, et al. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 2000; 275: 25781-90.
113. Glembot TM, Britt LD, Hill MA. Endotoxin interacts with tumor necrosis factor-alpha to induce vasodilation of isolated rat skeletal muscle arterioles. Shock 1996; 5: 251-7.
114. Wang P, Ba ZF, Chaudry IH. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol 1994; 266: H2535-41.
115. Davis JR, Giardina JB, Green GM, et al. Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 2002; 282: R390-9.
116. Giardina JB, Green GM, Cockrell KL, et al. TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: R130-43.
117. Worrall NK, Chang K, LeJeune WS, et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 1997; 273: H2565-74.
118. Wagner EM. TNF-alpha induced bronchial vasoconstriction. Am J Physiol Heart Circ Physiol 2000; 279: H946-51.
119. Greenberg S, Xie J, Wang Y, et al. Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. J Appl Physiol 1993; 74: 2394-403.
120. Baxter G. Effects of tumor necrosis factor on in vitro digital arterial responses in horses. Am J Vet Res 1994; 55: 551-5.
121. Mitaka C, Hirata Y, Ichikawa K, et al. Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. Am J Physiol 1994; 267: H1530-6.
122. Holm T, Aukrust P, Andreassen AK, et al. Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines. Clin Transplant 2000; 14: 218-25.
123. Iversen PO, Nicolaysen A, Kvernebo K, et al. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch 1999; 439: 93-100.
124. Nakamura M, Yoshida H, Arakawa N, et al. Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 2000; 36: 487-92.
125. White LR, Juul R, Skaanes KO, et al. Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. Eur J Pharmacol 2000; 406: 117-22.
126. Martens FM, Rabelink TJ, op 't Roodt J, et al. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. Eur Heart J 2006; 27: 1605-9.
127. Pickkers P, Netea MG, van der Meer JW, et al. TNFalpha and IL-1beta exert no direct vasoactivity in human isolated resistance arteries. Cytokine 2002; 20: 244-6.
128. Kupatt C, Habazettl H, Goedecke A, et al. Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ Res 1999; 84: 392-400.
129. Zhang C, Xu X, Potter BJ, et al. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2006; 26: 475-80.
130. Gao X, Xu X, Belmadani S, et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007; 27: 1269-75.
131. Gilmont RR, Dardano A, Engle JS, et al. TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. J Surg Res 1996; 61: 175-82.
132. Picchi A, Gao X, Belmadani S, et al. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006; 99: 69-77.
133. Gao X, Belmadani S, Picchi A, et al. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 2007; 115: 245-54.